Lydia Meziani

6PUBLICATIONS
16CO-AUTHORS
NanophotonicsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Context-Dependent Radioenhancement by Platinum Nanoparticles Under Conventional and Ultra-High Dose-Rate "FLASH" Radiotherapy.

|Jun 30, 2025
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect.

Pierre-Antoine Laurent, Liu Shi, Lisa Bouarroudj

|Oct 13, 2024
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.

Paul Bergeron, Morgane Dos Santos, Lisa Sitterle

|Jun 03, 2023
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation.

Lydia Meziani, Marine Gerbé de Thoré, Céline Clémenson

|Mar 18, 2022
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy.

Pauline Hamon, Marine Gerbé De Thoré, Marion Classe

|Jun 24, 2020
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages.

Lydia Meziani, Marine Gerbé de Thoré, Pauline Hamon

Pageof 1

Frequent Collaborators

4 joint publications

Michele Mondini

4 joint publications

Eric Deutsch

1 joint publications

Paul Bergeron

1 joint publications

Georges Tarlet